Search alternatives:
significant non » significant _ (Expand Search), significant amount (Expand Search), significant group (Expand Search)
gap increased » rate increased (Expand Search), care increased (Expand Search), gene increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
significant non » significant _ (Expand Search), significant amount (Expand Search), significant group (Expand Search)
gap increased » rate increased (Expand Search), care increased (Expand Search), gene increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
-
1
-
2
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
Published 2025Subjects: -
3
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
Published 2025Subjects: -
4
Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.
Published 2025Subjects: -
5
-
6
-
7
-
8
-
9
-
10
-
11
General information of patient who diagnosis insomnia disorder (N = 518,119).
Published 2025Subjects: -
12
-
13
-
14
-
15
Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.
Published 2023“…<p>Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.…”
-
16
-
17
-
18
-
19
-
20
Depleted antibody secreting cells did not result in decreased donor specific antibody in non-sensitized animals.
Published 2022“…(A) T (CD3<sup>+</sup>) and (B) B (CD45R<sup>+</sup>) cell flow crossmatch was performed in non-sensitized animals. IgG1<sup>+</sup> in the T cell flow crossmatch was the only DSA that BLyS<sup>-/-</sup> significantly decreased compared to APRIL<sup>-/-</sup> (p<0.03). …”